Src-family kinase-dependent disruption of endothelial barrier function by Plasmodium falciparum merozoite proteins

Blood

Volumn 110, Issue 9, 2007, Pages 3426-3435

  Gillrie, Mark R ^a   Krishnegowda, Gowdahalli ^b   Lee, Kristine ^a   Buret, Andre G ^a   Robbins, Stephen M ^c   Looareesuwan, S ^d   Gowda, D Channe ^b   Ho, May ^a,e  

^a UNIVERSITY OF CALGARY   (Canada)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

^d MAHIDOL UNIVERSITY   (Thailand)

^e NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN 5; CYTOSKELETON PROTEIN; GLYCOSYLPHOSPHATIDYLINOSITOL; PROTEIN TYROSINE KINASE; PROTEIN ZO1; PROTOZOAL PROTEIN; VASCULAR ENDOTHELIAL CADHERIN;

ARTICLE; BLOOD VESSEL PERMEABILITY; CELL DEATH; CELL DISRUPTION; CELL MEMBRANE; CELL NUCLEUS MEMBRANE; CONTROLLED STUDY; CYTOSKELETON; CYTOSOL; CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALARIA; MEMBRANE DAMAGE; MEROZOITE; MICROVASCULATURE; MONOLAYER CULTURE; NONHUMAN; PARASITE ISOLATION; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN LOCALIZATION; VASCULAR ENDOTHELIUM;

EID: 36148932964     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-04-084582     Document Type: Article

References (44)

1. Dejana E. Endothelial cell-cell junctions: happy together. Nat Rev Mol Cell Biol. 2004;5:261-270.
2. Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol Rev. 2006;86:279-367.
3. White NJ, Ho M. The pathophysiology of malaria. Adv Parasitol. 1992;31:83-173.
4. Medena IM, Turner GD. Human cerebral malaria and the blood brain barrier. Int J Parasitol. 2006;36:555-568.
5. Looareesuwan S, Warrell DA, White NJ, et al. Do patients with cerebral malaria have cerebral oedema? A computed tomography study. Lancet. 1983;1:434-437.
6. Looareesuwan S, Wilairatana P, Krishna S, et al. Magnetic resonance imaging of the brain in patients with cerebral malaria. Clin Infect Dis. 1995;21:300-309.
7. Newton CR, Peshu N, Kendall B, et al. Brain swelling and ischaemia in Kenyans with cerebral malaria. Arch Dis Child. 1994;70:281-287.
8. Brown HC, Chau TTH, Mai NTH, et al. Blood brain barrier function in cerebral malaria and CNS infections in Vietnam. Neurology. 2000;55:104-111.
9. Brown H, Rogerson S, Taylor TT, et al. Blood brain barrier function in cerebral malaria in Malawian children. Am J Trop Med Hyg. 2001;64:207-213.
10. Brown H, Tien TT, Day N, et al. Evidence of blood-brain barrier dysfunction in human cerebral malaria. Neuropathol Appl Neurobiol. 1999;25:331-340.
11. Taylor TE, Fu WJ, Carr RA, et al. Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat Med. 2004;10:143-145.
12. Taylor WR, Cannon V, White NJ. Pulmonary manisfestation of malaria: recognition and management. Treat Respir Med. 2006;5:419-428.
13. Robinson T, Mosha F, Grainge M, Madeley R. Indicators of mortality in African adults with malaria. Trans Roy Soc Trop Med Hyg. 2006;100:719-724.
14. Bruneel F, Hocqueloux L, Alberti C, et al. The clinical spectrum of severe imported falciparum malaria in the intensive care unit: report of 188 cases in adults. Am J Respir Crit Care Med. 2003;167:684-689.
15. Maguire GP, Handojo T, Pain MCF, et al. Lung injury in uncomplicated and severe falciparum malaria: a longitudinal study in Papua, Indonesia. J Infect Dis. 2005;192:1966-1974.
16. Yipp BG, Anand S, Schollaardt T, Patel KD, Looareesuwan S, Ho M. Synergism of multiple adhesion molecules in mediating cytoadherence of Plasmodium falciparum-infected to microvascular endothelial cells under flow. Blood. 2000;96:2292-2298.
17. Foote SJ, Kyle DE, Martin RK, et al. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature. 1990;345:255-258.
18. Naik RS, Branch OH, Woods AS, et al. Glycosylphosphatidylinositol anchors of Plasmodium falciparum: molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis. J Exp Med. 2000;192:1563-1576.
19. Coban C, Ishii KJ, Kawai T, et al. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J Exp Med. 2005;201:19-25.
20. Sullivan DJ Jr, Gluzman IY, Russell DG, Goldberg DE. On the molecular mechanism of chloroquine's antimalarial action. Proc Natl Acad Sci U S A. 1996;93:11865-11870.
21. Okutani D, Lodyga M, Han B, Liu M. Src protein tyrosine kinase family and acute inflammatory responses. Am J Physiol Lung Cell Mol Physiol. 2006;291:L129-L141.
22. Krishnegowda G, Hajjar AM, Zhu J, et al. Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity. J Biol Chem. 2005;280:8606-8616.
23. Olliaro P, Lombardi L, Frigerio S, Basilico N, Taramelli D, Monti D. Phagocytosis of hemozoin (native and synthetic malaria pigment), and Plasmodium falciparum intraerythrocyte-stage parasites by human and mouse phagocytes. Ultrastruct Pathol. 2000;24:9-13.
24. Parroche P, Lauw FN, Gontagny N, et al. Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc Natl Acad Sci U S A. 2007;104:1919-1924.
25. Brooks MH, Kiel FW, Sheehy TW, Barry KG. Acute pulmonary edema in falciparum malaria. N Engl J Med. 1968;279:732-737.
26. Tjitra E, Suprianto S, McBrown J, Currie BJ, Anstey NM. Persistent ICT malaria P.f./P.v. panmalarial and HRP2 antigen reactivity after treatment of Plasmodium falciparum malaria is associated with gametocytemia and results in false positive diagnosis of Plasmodium vivax in convalescence. J Clin Microbiol. 2001;39:1025-1031.
27. Wheeler AP, Bernard GR. Acute lung injury and the ARDS: a clinical review. Lancet. 2007;369:1553-1564.
28. Anstey NM, Handojo T, Pain MCF, et al. Lung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and post-treatment alveolar-capillary inflammation. J Infect Dis. 2007;195:589-596.
29. Dewi BE, Takasaki T, Kurane I. In vitro assessment of human endothelial cell permeability: effect of inflammatory cytokines and dengu virus infection. J Virol Meth.2004;121:171-180.
30. Weis S, Shintani S, Weber A, et al. Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction. J Clin Invest. 2004;113:885-894.
31. Pedram A, Razandi M, Levin ER. Deciphering vascular endothelial cell growth factor/vascular permeability factor signaling to vascular permeability: inhibition by atrial natriuretic peptide. J Biol Chem. 2002;277:44385-44398.
32. Eliceiri BP, Puente XS, Hood JD, et al. Src-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signaling. J Cell Biol. 2002;157:149-160.
33. Sun H, Breslin JW, Zhu J, Yuan SY, Wu MH. Rho and ROCK signaling in VEGF-induced microvascular endothelial hyperpermeability. Microcirculation. 2006;13:237-247.
34. Angelini DJ, Hyun SW, Grigoryev DN, et al. TNF-α increases tyrosine phosphorylation of vascular endothelial cadherin and opens the paracellular pathway through fyn activation in human lung endothelia. Am J Physiol Lung Cell Mol Physiol. 2006;291:L1232-L1245.
35. Stamatovic SM, Dimitrijevic OB, Keep RF, Andjelkovic AV. Protein kinase C alpha-RhoA cross-talk in CCL2-induced alterations in brain endothelial permeability. J Biol Chem. 2006;281:8379-8388.
36. Wassmer SC, Combes V, Candal FJ, Juhan-Vague I, Grau GE. Platelet potentiates brain endothelial alterations induced by P. falciparum. Infect Immun. 2006;74:645-653.
37. Wassmer SC, de Souza JB, Frere C, Candal FJ, Juhan-Vague I, Grau GE. TGF-beta released from activated platelets can induce TNF-stimulated human brain endothelium apoptosis: a new mechanism for microvascular lesions during cerebral malaria. J Immunol. 2006;176:1180-1184.
38. Tripathi AK, Sullivan DJ, Stins MF. Plasmodium falciparum-infected erythrocytes decrease the integrity of human blood-brain barrier endothelial cell monolayers. J Infect Dis. 2007;195:942-950.
39. Elliott SR, Spurck TP, Dodin JM, et al. Inhibition of dendritic cell maturation by malaria is dose dependent and does not require Plasmodium falciparum erythrocyte membrane protein 1. Infect Immun. 2007;75:3621-3632.
40. Silamut K, Phu NH, Whitty C, et al. A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain. Am J Pathol. 1999;155:395-410.
41. Debierre-Grockiego F, Schofield L, Azzouz N, et al. Fatty acids from Plasmodium falciparum down-regulate the toxic activity of mlaria glycosylphosphatidylinositols. Infect Immun. 2006;74:5487-5496.
42. Taramelli D, Basilico N, De Palma AM, et al. The effect of synthetic malaria pigment (beta-haematin) on adhesion molecule expression and interleukin-6 production by human endothelial cells. Trans R Soc Trop Med Hyg. 1998;92:57-62.
43. Skorokhod OA, Alessio M, Mordmuller B, Arese P, Schwarzer E. Hemozoin (malarial pigment) inhibits differentiation and maturation of human monocyte-derived dendritic cells: a peroxisome proliferator-activated receptor-gamma-mediated effect. J Immunol. 2004;173:4066-4074.
44. Augustijn KD, Kleemann R, Thompson J, et al. Functional characterization of the Plasmodium falciparum and P. berghei homologues of macrophage migration inhibitory factor. Infect Immun. 2007;75:1116-1128.